Search

Search Results

• GLP-1 agonists in anaesthetic practice - a review of clinical data and recommendations

  Natalia Pokrywka, Marcelina Polak, Dawid Suwała, Paulina Hetnar, Milena Fortuna, Sebastian Kiper, Sławomir Toczek, Magdalena Tomala , Katarzyna Jastrowicz-Chęć, Klaudia Koryszko

  61812

  2025-07-14
• Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists

  Adrianna Tabeau, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Justyna Pięta, Hanna Sitarek, Joanna Prus, Marcel Chudzikowski, Agata Prokopiuk

  53347

  2025-03-25
• Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review

  Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

  57712

  2025-02-06
• Adverse effects of GLP – 1 Receptor Agonists

  Anna Kasprzak, Monika Kułaga, Monika Grzybek, Diana Mazur-Lesińska, Barbara Szostak, Sylwia Wielgosz-Biała, Krzysztof Tyszkiewicz, Borys Łozowski, Małgorzata Kasprzak, Barbara Wilczyńska

  57774

  2025-02-11
• Potential benefits of GLP-1 analogues and metformin in patients with osteoarthritis

  Anna Skowronek, Martyna Piekarska, Katarzyna Dąbek, Michał Ochwat, Maria Sudoł, Gabriela Mierzwa, Aleksandra Kajtel, Tomasz Skowronek

  56953

  2025-01-07
• Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment

  Hanna Sitarek, Adrianna Tabeau, Joanna Prus, Justyna Pięta, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Marcel Chudzikowski, Agata Prokopiuk

  59642

  2025-05-06
• The Impact of GLP-1 Analogues and Tirzepatide on Female Fertility: Mechanisms, Clinical Evidence, and Implications

  Klaudia Elżbieta Niwińska, Michał Borowski, Julia Aleksandra Leśniak, Natalia Maria Leśniak, Klaudia Martyna Patrzykąt, Anna Maria Zakrzewska, Kinga Popielarska, Julia Agnieszka Michalak, Monika Augustyn, Aleksander Midera

  67444

  2026-01-16
• GLP-1 Receptor Agonists: A New Hope in the Global Fight Against Obesity — Benefits and Health Risks

  Oskar Pastuszek, Konrad Borowski, Maja Radziwon, Emilia Bolesta-Okuniewska, Paweł Michalak, Aleksandra Marchwińska-Pancer, Katarzyna Kopeć, Julia Ceryn, Anna Wicher

  67433

  2026-01-11
• Semaglutide and Other GLP-1 Receptor Agonists as Potential Therapies for Addiction – Mechanisms, Evidence, and Clinical Implications

  Katarzyna Wajda, Wiktoria Mika, Justyna Słowik, Izabela Sieradzka

  66921

  2025-12-12
• Incretin hormone agonists as promising antiobesity drugs - review of literature

  Aleksandra Grzegorczyk, Justyna Korus, Marta Dziedziak, Nicol Dardzińska, Natalia Hopej

  56677

  2025-01-09
• GLP-1 Receptor Agonists in Alcohol Use Disorder: Neurobiological Mechanisms and Therapeutic Potential

  Zuzanna Czach, Dominika Bachurska, Magdalena Ignarska, Justyna Ignarska, Oliwia Grygorczuk, Karolina Krzyżanowska

  66493

  2025-11-17
• The Neuroprotective Effects of GLP-1 Analogues on Alzheimer's Disease – A Literature Review

  Wiktoria Ulicka, Patryk Dudek, Klaudia Łuczak, Marcel Chudzikowski, Agnieszka Pawlik, Justyna Pięta, Adrianna Tabeau, Hanna Sitarek, Joanna Prus, Agata Prokopiuk

  59398

  2025-04-22